US life sciences consulting firm and incubator invests in Cortical Dynamics Ltd
Hey! Looks like you have stumbled on the section of our website where we have archived articles from our old business model.
In 2019 the original founding team returned to run Next Investors, we changed our business model to only write about stocks we carefully research and are invested in for the long term.
The below articles were written under our previous business model. We have kept these articles online here for your reference.
Our new mission is to build a high performing ASX micro cap investment portfolio and share our research, analysis and investment strategy with our readers.
Click Here to View Latest Articles
BPH Energy Limited (ASX:BPH) has announced that investee Cortical Dynamics has secured a $250,000 investment from IntuitiveX and Korean based VC investor, Gentium Partners.
Cortical is an Australian based medical device technology company that developed a next generation Brain Function Monitor and is now commercialising the intellectual property.
Its core product, the Brain Anaesthesia Response (BARM) System, was developed to better detect the effect of anaesthetic agents on brain activity.
IntuitiveX (www.intuitive-x.com) is a Seattle-based life science consulting firm and incubator that brings to Cortical extensive experience in the US capital raising and commercialisation arena and will assist Cortical in the FDA regulatory approval process.
The IntuitiveX management team is comprised of life science entrepreneurs, physicians, investors, and innovators and brings a combined 100+ years of experience in R&D, clinical, IP strategy, prototyping, product development, and commercialisation. It has investments in eleven MedTech, digital health, robotics to augmented reality, and 3-D printing to biotech.
Korean asset management company, Gentium Partners (GP) assists venture companies, particularly those in the startup stages, with mentoring and fund raising. GP prefers to invest in companies with innovative technologies and/or ideas, particularly when they are impactful in healthcare, environment, and lifestyle.
Mr Charles Chang and Mr Ashley Zimpel will join the Cortical board following the resignations of other Cortical directors, while BPH director David Breeze remains as a Cortical board member.
Cortical Dynamics is working with BPH Energy, which currently holds 4.38% of Cortical Dynamics, and Swinburne University of Technology to develop and commercialise a unique depth of anaesthesia monitoring system for use during major surgery.
Cortical’s BARM System is applied via an adhesive sensor to the forehead, to measure a patient’s brain electrical activity, the electroencephalogram (EEG), in order to indicate how deeply anaesthetised a patient is during an operation. This aids anaesthetists in keeping patients optimally anaesthetised, ensuring patients do not wake unexpectedly, and it reduces the incidence of side effects associated with the anaesthetic.
In addition to Cortical Dynamics, BPH has an investment in the medicinal cannabis space via Patagonia Genetics Pty Ltd. BPH Energy’s major investment is in Advent Energy Ltd, an unlisted oil and gas exploration and development company with onshore and offshore exploration and near-term development assets around Australia.
General Information Only
S3 Consortium Pty Ltd (S3, ‘we’, ‘us’, ‘our’) (CAR No. 433913) is a corporate authorised representative of LeMessurier Securities Pty Ltd (AFSL No. 296877). The information contained in this article is general information and is for informational purposes only. Any advice is general advice only. Any advice contained in this article does not constitute personal advice and S3 has not taken into consideration your personal objectives, financial situation or needs. Please seek your own independent professional advice before making any financial investment decision. Those persons acting upon information contained in this article do so entirely at their own risk.
Conflicts of Interest Notice
S3 and its associated entities may hold investments in companies featured in its articles, including through being paid in the securities of the companies we provide commentary on. We disclose the securities held in relation to a particular company that we provide commentary on. Refer to our Disclosure Policy for information on our self-imposed trading blackouts, hold conditions and de-risking (sell conditions) which seek to mitigate against any potential conflicts of interest.
Publication Notice and Disclaimer
The information contained in this article is current as at the publication date. At the time of publishing, the information contained in this article is based on sources which are available in the public domain that we consider to be reliable, and our own analysis of those sources. The views of the author may not reflect the views of the AFSL holder. Any decision by you to purchase securities in the companies featured in this article should be done so after you have sought your own independent professional advice regarding this information and made your own inquiries as to the validity of any information in this article.
Any forward-looking statements contained in this article are not guarantees or predictions of future performance, and involve known and unknown risks, uncertainties and other factors, many of which are beyond our control, and which may cause actual results or performance of companies featured to differ materially from those expressed in the statements contained in this article. S3 cannot and does not give any assurance that the results or performance expressed or implied by any forward-looking statements contained in this article will actually occur and readers are cautioned not to put undue reliance on forward-looking statements.
This article may include references to our past investing performance. Past performance is not a reliable indicator of our future investing performance.